Cargando…

Targeted dual-color silica nanoparticles provide univocal identification of micrometastases in preclinical models of colorectal cancer

BACKGROUND AND METHODS: Despite the recent introduction of targeted bio-drugs, the scarcity of successful therapeutic options for advanced colorectal cancer remains a limiting factor in patient management. The efficacy of curative surgical interventions can only be extended through earlier detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Soster, Marco, Juris, Riccardo, Bonacchi, Sara, Genovese, Damiano, Montalti, Marco, Rampazzo, Enrico, Zaccheroni, Nelsi, Garagnani, Paolo, Bussolino, Federico, Prodi, Luca, Marchiò, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439856/
https://www.ncbi.nlm.nih.gov/pubmed/22973099
http://dx.doi.org/10.2147/IJN.S33825
Descripción
Sumario:BACKGROUND AND METHODS: Despite the recent introduction of targeted bio-drugs, the scarcity of successful therapeutic options for advanced colorectal cancer remains a limiting factor in patient management. The efficacy of curative surgical interventions can only be extended through earlier detection of metastatic foci, which is dependent on both the sensitivity and specificity of the diagnostic tools. RESULTS: We propose a high-performance imaging platform based on silica-poly(ethylene glycol) nanoparticles doped with rhodamine B and cyanine 5. Simultaneous detection of these dyes is the basis for background subtraction and signal amplification, thus providing high-sensitivity imaging. The functionalization of poly(ethylene glycol) tails on the external face of the nanoparticles with metastasis-specific peptides guarantees their homing to and accumulation at target tissues, resulting in specific visualization, even of submillimetric metastases. CONCLUSIONS: The results reported here demonstrate that our rationally designed modular nanosystems have the ability to produce a breakthrough in the detection of micrometastases for subsequent translation to clinics in the immediate future.